Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Gene Therapy 2 for Oncology by Alaunos Therapeutics for Leukemia: Likelihood of Approval
Gene Therapy 2 for Oncology is under clinical development by Alaunos Therapeutics and currently in Phase I for Leukemia. According...
Data Insights
Gene Therapy 2 for Oncology by Alaunos Therapeutics for Lymphoma: Likelihood of Approval
Gene Therapy 2 for Oncology is under clinical development by Alaunos Therapeutics and currently in Phase I for Lymphoma. According...